These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 7273479)

  • 1. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific circulating immune complexes in patients with hepatitis B].
    Chang ML; Chou CT; Chao YC; Lee CF; Chang DM; Hsu K
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):119-26. PubMed ID: 3652780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior and clinical significance of the eAg/ anti-e system in carriers of HBsAg].
    Pastore G; Dentico P; Fera G; Angarano G; Schiraldi O
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):333-8. PubMed ID: 911461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers].
    Chang ML; Chou CT; Lee CF; Chang DM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes in patients with acute and chronic diseases of the liver].
    Uibo RM; Nutt HR; Prjukk TJ
    Ter Arkh; 1989; 61(2):61-4. PubMed ID: 2524905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Course control and significance of circulating HBsAg-specific immune complexes in acute viral hepatitis B].
    Markus R; Baumgarten R; Fengler JD; Richter H; Apostoloff E
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(4):229-42. PubMed ID: 3803280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating HBsAg/IgM complexes in acute and chronic hepatitis B.
    Musca A; Cordova C; Barnaba V; Zaccari C; Levrero M; van Dyke A; Balsano F
    Hepatogastroenterology; 1984 Oct; 31(5):208-10. PubMed ID: 6510881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B surface antigen and immunoglobulin M complexes in chronic carriers and patients with acute and chronic liver diseases.
    Ayoola EA; Olubuyide I
    Afr J Med Med Sci; 1989 Mar; 18(1):21-4. PubMed ID: 2545079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
    Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
    Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and quantitation of hepatitis B surface antigen immune complexes (HBsAg-ICs) by an antigen-specific method. II. Circulating immune complexes (CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    J Immunol Methods; 1980; 35(3-4):307-18. PubMed ID: 6156971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. A marker of immune-mediated hepatocellular damage?
    Biglino A; Cariti G; Gioannini P
    Boll Ist Sieroter Milan; 1985; 64(3):201-6. PubMed ID: 2412572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexes.
    Caredda F; De Franchis R; D'Arminio Monforte A; Vecchi M; Antoniozzi F; Rossi E; Primignani M; Moroni M
    Boll Ist Sieroter Milan; 1984; 63(6):496-8. PubMed ID: 6534395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection: detection of circulating HBsAg/IgM antibody immune complexes.
    Surelia P; Boxall EH
    Med Lab Sci; 1990 Jul; 47(3):204-9. PubMed ID: 2402200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N; Ozen H; Yüce A; Gürakan F
    Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R
    Z Gesamte Inn Med; 1990 Oct; 45(20):623-5. PubMed ID: 2099582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection.
    Pernice W; Sodomann CP; Lüben G; Seiler FR; Sedlacek HH
    Clin Exp Immunol; 1979 Aug; 37(2):376-80. PubMed ID: 91465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature and incidence of cryoproteins in hepatitis B antigen (HbsAg) positive patients.
    Mcintosh RM; Koss MN; Gocke KJ
    Q J Med; 1976 Jan; 45(177):23-38. PubMed ID: 130650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen.
    Brown SE; Howard CR; Steward MW; Viola L; Murray-Lyon IM
    Dev Biol Stand; 1983; 54():391-7. PubMed ID: 6653894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.